MBX Biosciences Inc (NAS:MBX)
$ 62.08 -1.57 (-2.47%) Market Cap: 2.95 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 6.75 GF Score: 12/100

MBX Biosciences Inc Annual Shareholders Meeting Transcript

Jun 04, 2026 / 12:00PM GMT
Release Date Price: $30.91 (+2.86%)
Jim Denike
MBX Biosciences Inc - Senior Director - Investor Relations and Communications

Hello, welcome to the 2026 virtual annual meeting of MBX Biosciences. My name is Jim DeNike, and I'm the company's Senior Director of Investor Relations and Communications. Please note that today's meeting is being recorded.

You also have the ability to ask questions in writing through the virtual meeting platform via the Ask a Question section, and we will consider any questions and follow up after this meeting as applicable.

At this time, I'd like to turn the call over to Kent Hawryluk, the company's President and Chief Executive Officer.

P. Kent Hawryluk
MBX Biosciences Inc - President, Chief Executive Officer, Director

Good morning. The meeting is now called to order. I've asked Caitlin Murray, our legal counsel, to record the minutes. It is a pleasure to welcome our stockholders to our annual meeting. This meeting is being held in accordance with the corporation's bylaws and Delaware law. Our meeting today will address the business described in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot